Search Login Register

Hydroxyurea (Hydrea) Summary

Description: An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.

Also Known As: Hydrea; Oncocarbide; Hydroxycarbamid; Urea, hydroxy-

Networked: 2417 relevant articles (196 outcomes, 338 trials/studies) for this Drug

Key Diseases for which Hydroxyurea is Relevant

  1. Sickle Cell Anemia (Hemoglobin S Disease) : 62 outcomes 79 studies in 519 results
  2. beta-Thalassemia (Cooley's Anemia) : 10 outcomes 14 studies in 83 results
  3. Neoplasms (Cancer) : 9 outcomes 37 studies in 237 results
  4. Pain (Aches) : 8 outcomes 8 studies in 56 results
  5. Polycythemia Vera : 8 outcomes 7 studies in 109 results
Show All >>

Drugs Related to Hydroxyurea

  1. Fetal Hemoglobin (Hemoglobin F)
  2. anagrelide (Agrylin)
  3. imatinib (Gleevec)
  4. Busulfan (Busulfex)
  5. Ribonucleotide Reductases (Ribonucleotide Reductase)
  6. Aspirin (Acetylsalicylic Acid)
  7. Interferon-alpha (Interferon Alfa)
  8. Hemoglobins (Hemoglobin)
  9. Cytarabine (Cytosar-U)
  10. Interferons
Show All >>

Therapies Related to Hydroxyurea

  1. Drug Therapy (Chemotherapy)
  2. Transplantation (Transplant Recipients)
  3. Blood Transfusion (Blood Transfusions)
  4. Radiotherapy
  5. Bone Marrow Transplantation (Transplantation, Bone Marrow)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.